Application 090444

Type: ANDA
Sponsor: LUPIN LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	IMIPRAMINE PAMOATE	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 75MG HYDROCHLORIDE	No	No
002	IMIPRAMINE PAMOATE	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 100MG HYDROCHLORIDE	No	No
003	IMIPRAMINE PAMOATE	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 125MG HYDROCHLORIDE	No	No
004	IMIPRAMINE PAMOATE	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 150MG HYDROCHLORIDE	No	No

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
57297-314	Imipramine Pamoate	Imipramine Pamoate	LUPIN LIMITED	ANDA	Current
57297-315	Imipramine Pamoate	Imipramine Pamoate	LUPIN LIMITED	ANDA	Current
57297-316	Imipramine Pamoate	Imipramine Pamoate	LUPIN LIMITED	ANDA	Current
57297-317	Imipramine Pamoate	Imipramine Pamoate	LUPIN LIMITED	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-314	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-315	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-316	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current
68180-317	Imipramine Pamoate	Imipramine Pamoate	Lupin Pharmaceuticals, Inc.	ANDA	Current

Application 090444

Related Records#

Application Products#

NDC Listings For This Application#